LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)
$4.39 0.05 (1.1521%)
Analysed LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) News Sources
Lifecore Biomedical to Participate at CDMO Live Europe
12-05-2026
yahoo.com
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
21-05-2026
yahoo.com
How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations
29-05-2026
yahoo.com
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
02-06-2026
yahoo.com
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook
13-06-2026
yahoo.com
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
15-06-2026
yahoo.com
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
30-06-2026
yahoo.com
Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market
15-07-2026
yahoo.com
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
15-07-2026
yahoo.com
Lifecore Biomedical Signs Three New Customer Agreements
28-07-2026
yahoo.com
What is the current price of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The current price of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is $4.39.
LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) since the previous trading day is $0.05.
LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) since the previous trading day is 1.1521%.
What is the most recent average sentiment score for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The most recent average sentiment score for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The most recent sentiment for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is .
SEC-8K** Filing Available For LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.